HTEC vs. IBB
HTEC (ROBO Global Healthcare Technology and Innovation ETF) and IBB (iShares Nasdaq Biotechnology ETF) are both Health & Biotech Equities funds - HTEC tracks the ROBO Global® Healthcare Technology and Innovation Index while IBB tracks the NASDAQ Biotechnology Index. Both are passively managed. Over the past 5 years, HTEC returned -4.88%/yr vs 2.10%/yr for IBB. Their correlation of 0.84 suggests significant overlap in exposure. HTEC charges 0.68%/yr vs 0.47%/yr for IBB.
Performance
HTEC vs. IBB - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, HTEC achieves a -2.96% return, which is significantly lower than IBB's -0.68% return.
HTEC
- 1D
- 0.67%
- 1M
- 3.12%
- YTD
- -2.96%
- 6M
- -3.90%
- 1Y
- 26.68%
- 3Y*
- 5.17%
- 5Y*
- -4.88%
- 10Y*
- —
IBB
- 1D
- 1.97%
- 1M
- -1.56%
- YTD
- -0.68%
- 6M
- -2.57%
- 1Y
- 34.50%
- 3Y*
- 9.40%
- 5Y*
- 2.10%
- 10Y*
- 6.23%
HTEC vs. IBB - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
HTEC ROBO Global Healthcare Technology and Innovation ETF | -2.96% | 23.91% | 2.68% | -2.94% | -33.72% | -0.28% | 65.01% | 9.34% |
IBB iShares Nasdaq Biotechnology ETF | -0.68% | 27.98% | -2.41% | 3.76% | -13.69% | 0.95% | 26.01% | 12.93% |
Correlation
The correlation between HTEC and IBB is 0.74, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.74 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.79 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.84 |
Correlation (All Time) Calculated using the full available price history since Jun 26, 2019 | 0.84 |
The correlation between HTEC and IBB has been stable across timeframes, ranging from 0.74 to 0.84 - a consistent structural relationship.
HTEC vs. IBB - Sectors Allocation Comparison
Sectors
HTEC
IBB
Healthcare
Financial Services
-
Technology
-
Industrials
-
Energy
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Real Estate
-
-
Utilities
-
-
Healthcare
HTEC
IBB
Financial Services
HTEC
IBB
-
Technology
HTEC
IBB
-
Industrials
HTEC
IBB
-
Energy
HTEC
IBB
-
Basic Materials
HTEC
-
IBB
-
Communication Services
HTEC
-
IBB
-
Consumer Cyclical
HTEC
-
IBB
-
Consumer Defensive
HTEC
-
IBB
-
Real Estate
HTEC
-
IBB
-
Utilities
HTEC
-
IBB
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HTEC vs. IBB — Risk / Return Rank
HTEC
IBB
HTEC vs. IBB - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ROBO Global Healthcare Technology and Innovation ETF (HTEC) and iShares Nasdaq Biotechnology ETF (IBB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| HTEC | IBB | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.42 | ||
| Sortino ratioReturn per unit of downside risk | -0.52 | ||
| Omega ratioGain probability vs. loss probability | 1.23 | 1.30 | -0.07 |
| Calmar ratioReturn relative to maximum drawdown | 1.64 | 3.60 | -1.96 |
| Martin ratioReturn relative to average drawdown | 4.07 | 11.43 | -7.35 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| HTEC | IBB | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.32 | 1.74 | -0.42 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.20 | 0.10 | -0.30 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.27 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.21 | 0.26 | -0.05 |
Drawdowns
HTEC vs. IBB - Drawdown Comparison
The maximum HTEC drawdown since its inception was -57.53%, smaller than the maximum IBB drawdown of -62.85%. Use the drawdown chart below to compare losses from any high point for HTEC and IBB.
Loading charts...
Drawdown Indicators
| HTEC | IBB | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -57.53% | -62.85% | +5.32% |
Max Drawdown (1Y)Largest decline over 1 year | -16.31% | -9.63% | -6.68% |
Max Drawdown (3Y)Largest decline over 3 years | -28.67% | -24.85% | -3.82% |
Max Drawdown (5Y)Largest decline over 5 years | -56.10% | -39.82% | -16.28% |
Max Drawdown (10Y)Largest decline over 10 years | — | -39.82% | — |
Current DrawdownCurrent decline from peak | -33.25% | -5.64% | -27.61% |
Average DrawdownAverage peak-to-trough decline | -28.99% | -21.18% | -7.81% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.57% | 3.03% | +3.54% |
Volatility
HTEC vs. IBB - Volatility Comparison
The current volatility for ROBO Global Healthcare Technology and Innovation ETF (HTEC) is 5.82%, while iShares Nasdaq Biotechnology ETF (IBB) has a volatility of 6.86%. This indicates that HTEC experiences smaller price fluctuations and is considered to be less risky than IBB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HTEC | IBB | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.82% | 6.86% | -1.04% |
Volatility (6M)Calculated over the trailing 6-month period | 14.90% | 15.38% | -0.48% |
Volatility (1Y)Calculated over the trailing 1-year period | 20.32% | 19.89% | +0.43% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 24.39% | 21.99% | +2.40% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 25.46% | 23.22% | +2.24% |
HTEC vs. IBB - Expense Ratio Comparison
HTEC has a 0.68% expense ratio, which is higher than IBB's 0.47% expense ratio.
Dividends
HTEC vs. IBB - Dividend Comparison
HTEC's dividend yield for the trailing twelve months is around 1.01%, more than IBB's 0.23% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
HTEC ROBO Global Healthcare Technology and Innovation ETF | 1.01% | 0.98% | 0.00% | 0.00% | 0.00% | 0.05% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
IBB iShares Nasdaq Biotechnology ETF | 0.23% | 0.23% | 0.29% | 0.26% | 0.31% | 0.21% | 0.21% | 0.33% | 0.20% | 0.30% | 0.19% | 0.03% |
Frequently Asked Questions
HTEC and IBB have a correlation of 0.74, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IBB has higher volatility (6.86%) compared to HTEC (5.82%). In terms of maximum drawdown, HTEC dropped -57.53% vs IBB's -62.85%.
On 5-year performance, IBB leads with 2.10% vs -4.88% for HTEC. On fees, IBB is cheaper at 0.47% per year. On volatility, HTEC has been the lower-risk option at 5.82%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, IBB has performed better with a 2.10% return vs -4.88%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
IBB is cheaper with a 0.47% expense ratio, compared with 0.68% for HTEC.
HTEC has the higher dividend yield at 1.01%, compared with 0.23% for IBB.
HTEC tracks ROBO Global® Healthcare Technology and Innovation Index, while IBB tracks NASDAQ Biotechnology Index. They also come from different issuers: Exchange Traded Concepts and iShares. Their fees differ too: 0.68% for HTEC and 0.47% for IBB.
IBB currently has the higher Sharpe Ratio (1.74 vs 1.32), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for HTEC and IBB
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer